Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › enoxaparin

enoxaparin

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of enoxaparin

41 trials tracked of enoxaparin: 18 in phase 3 or 4 and 4 with published results. The most-cited published study has 486 citations.

41Trials tracked
18Phase 3 & 4
0Recruiting
4With published results
Phase distribution
Phase 4 1 Phase 3 17 Phase 2 14 Phase 1 4 Other / NA 5
  1. Phase 3 Full Dose Heparin Vs. Prophylactic Or Intermediate Dose Heparin in High Risk COVID-19 Patients Completed · 486 cited
  2. Phase 3 Edoxaban vs. Warfarin in Subjects Undergoing Cardioversion of Nonvalvular Atrial Fibrillation (NVAF) Completed · 246 cited
  3. Phase 3 Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study) Completed · 21 cited
  4. Phase 3 STREAM-Strategic Reperfusion (With Tenecteplase and Antithrombotic Treatment) Early After Myocardial Infarction Completed · 7 cited
  5. Phase 4 Enoxaparin Dosing in Obesity Completed
  6. Phase 3 Regulation of Coagulation in Orthopedic Surgery to Prevent Deep Vein Thromboembolism (DVT) and Pulmonary Embolism (PE). A Study of BAY59-7939 in the Prevention of Venous Thrombo Embolism (VTE) in Subjects Undergoing Elective Total Knee Replacement. Completed
Show 35 more trials
  1. Phase 3 Prophylactic Enoxaparin Dosing for Prevention of Venous Thromboembolism in Pregnancy. Completed
  2. Phase 3 Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Hip Replacement Surgery (ADVANCE-3) Completed
  3. Phase 3 Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery Completed
  4. Phase 3 A Phase 3 Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty Completed
  5. Phase 3 A Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty Completed
  6. Phase 3 Dabigatran Etexilate Compared With Enoxaparin in Prevention of Venous Thromboembolism (VTE) Following Total Hip Arthroplasty Completed
  7. Phase 3 Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism Completed
  8. Phase 3 Dabigatran Etexilate in Extended Venous Thromboembolism (VTE) Prevention After Hip Replacement Surgery Completed
  9. Phase 3 Venous Thromboembolic Event (VTE) Prophylaxis in Medically Ill Patients Completed
  10. Phase 3 Dabigatran Etexilate vs Enoxaparin in Prevention of Venous Thromboembolism (VTE) Post Total Knee Replacement Completed
  11. Phase 3 Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness Completed
  12. Phase 3 RE-MODEL Dabigatran Etexilate 150mg or 220mg Once Daily (o.d.) Versus (v.s.) Enoxaparin 40mg o.d. for Prevention of Thrombosis After Knee Surgery Completed
  13. Phase 2 Weight-Based Enoxaparin Dosing and Real-Time Dose Adjustment in Orthopaedic Trauma Completed
  14. Phase 2 A Trial to Learn How Well REGN7508 Works for Preventing Blood Clots After a Knee Replacement in Adult Participants Completed
  15. Phase 2 BIBR 1048 Dose Range Finding Study in Prevention of Venous Thromboembolism in Patients With Primary Elective Total Hip or Knee Replacement Surgery Completed
  16. Phase 2 Enoxaparin Thromboprophylaxis in Cancer Patients With Elevated Tissue Factor Bearing Microparticles Completed
  17. Phase 2 Study to Assess the Safety, Pharmacokinetics/Dynamics of DS-1040b in Subjects With Acute Submassive Pulmonary Embolism Completed
  18. Phase 2 Adjuvant Treatment of Pulmonary Embolism With Drotrecogin Alfa (Activated): Phase II Exploratory Study Completed
  19. Phase 2 Study Of Weight-Based Versus Standard Dose Enoxaparin Thromboprophylaxis In High-Risk Hospitalized Cancer Patients Completed
  20. Phase 2 Low Molecular Weight Heparin or no Treatment Following Cesarean Delivery Completed
  21. Phase 2 Factor Xa Inhibitor, PRT054021, Against Enoxaparin for the Prevention of Venous Thromboembolic Events (EXPERT) Completed
  22. Phase 2 PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Participants With Stage IV Untreated Pancreatic Cancer Completed
  23. Phase 2 A Study to Evaluate Safety of Single Doses of BMS-986177 in Patients With End Stage Renal Disease (ESRD) Treated With Hemodialysis Completed
  24. Phase 2 A Trial to Learn How Well REGN9933 Works for Preventing Blood Clots After Knee Replacement Surgery in Adult Participants Completed
  25. Phase 2 Enoxaparin Metabolism in Reconstructive Surgery Patients Completed
  26. Phase 2 Study to Assess the Safety and Efficacy of SelK2 to Prevent Blood Clots in Patients Undergoing Total Knee Replacement Completed
  27. Phase 1 Bioavailability Study of Enoxaparin Sodium Chemi and Clexane s.c. Completed
  28. Phase 1 Comparing Anti-XA Levels in Post-Cesarean Patients Undergoing Enoxaparin Thromboprophylaxis Completed
  29. Phase 1 A Single-Dose Trial to Examine the Within Subject Variability of Clexane® in Healthy Adults Under Fasting Conditions Completed
  30. Phase 1 Delayed Versus Early Enoxaparin Prophylaxis After Traumatic Brain Injury (TBI) Completed
  31. N/A Enoxaparin Versus Aspirin in Patients With Cancer and Stroke Completed
  32. N/A Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer Completed
  33. N/A Once Daily Enoxaparin for Outpatient Treatment of Acute DVT and/or Pulmonary Embolism Completed
  34. N/A Aspirin and Compression Devices for VTE Prophylaxis in Orthopaedic Oncology Completed
  35. N/A Deep Vein Thrombosis (DVT) Prevention in Total Hip Arthroplasty: Continuous Enhanced Circulation Therapy (CECT) Versus Low Molecular Weight Heparin (LMWH) Completed

Showing the 41 most-cited and recently-updated of 41 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Saudi Arabia study finds most insulin and anticoagulant errors occur during prescribing
Drug Pipeline Cohort
Saudi Arabia study finds most insulin and anticoagulant errors occur during prescribing Insulin and Blood Thinners Behind Thousands of Drug Errors
This retrospective observational real-world study analyzed 63,817 medication error reports from Saudi Arabia involving adults (>18 years).
Insulin and blood thinners caused most of the 63,817 drug errors reported in Saudi Arabia between 2020 and 2023, with pharmacists catching t…
Frontiers Apr 19, 2026
Proceeding with TKA without preoperative anticoagulation for asymptomatic calf vein thrombosis shows no 90-day VTE events
Rheumatology Cohort
Proceeding with TKA without preoperative anticoagulation for asymptomatic calf vein thrombosis shows no 90-day VTE events Skip the delay for a minor clot before knee surgery
A retrospective cohort study of 454 adults undergoing primary unilateral TKA found that 44 patients with preoperative asymptomatic isolated …
A small, silent clot found before knee replacement does not require stopping surgery or adding extra blood thinners.
Frontiers Apr 9, 2026